About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

NCT03297775·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Haylie A Lengel
CONTACT
970-376-8303 haylie.lengel@cuanschutz.edu
Joyce S Lee, MD
CONTACT
303-724-6109 joyce.lee@ucdenver.edu

Lead

University of Colorado, Denver

Age

45–90

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

1. ≥ 45years old
2. Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria

You may not be if

1. Inability to give informed consent
2. Pregnant women
3. History of interstitial lung disease
4. Evidence of other causes of diffuse parenchymal lung disease such as infection, drug toxicity, other autoimmune processes, etc.
5. Subjects over the age of 90 years old or less than 45 years old

The record

StatusRecruiting

PhaseNo phase

Taking part750

StartedJun 2017

UpdatedMay 1, 2026

Conditions

Rheumatoid Arthritis Interstitial Lung Disease

Where1

University of Colorado - Anschutz Medical Campus
Aurora, Colorado, United States

Clareo Health | Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease